GSM Foils delivered robust FY26 results: Revenue soared 64.56% YoY to ₹331.83 Cr, with Q4 revenue up 39.31% to ₹184.82 Cr, fueled by strong demand for Blister & Pharma Foils. Net profit jumped 95.03% annually to ₹18.84 Cr (Q4: ₹11.61 Cr, +32.53% YoY).
However, full-year EPS rose just 0.66% to ₹7.58, impacted by a significant share capital increase. Expenses scaled with operations, but efficiency gains appear to have supported profitability.
These results signal mixed financial momentum, reflecting strong operational performance but diluted per-share earnings due to equity expansion.